HOME / Newsroom /
Illingworth Research Increases Clinical Trial Efficiency and Compliance with Montriums eTMF Connect Solution

Illingworth Research Increases Clinical Trial Efficiency and Compliance with Montriums eTMF Connect Solution

LONDON, UK, Oct. 17, 2017 - Montrium today announced that Illingworth Research Group has selected the Montrium's eTMF Connect solution to streamline global clinical operations and centralize collaboration with sponsors and sites.

Montrium's cloud capabilities offer a truly unique collaborative environment for emerging growth organizations within the life sciences, enabling partner organizations to connect through one platform. Illingworth Research Group now benefits from a robust and powerful electronic trial master file platform that streamlines the management of critical clinical trial content, providing clinical sites as well as sponsors a consistent interface for efficient and effective collaboration.

"eTMF Connect changes how our sponsors and partners work together through providing fast, direct access to critical TMF content and data," said Helen Springford, Vice President of Strategic Development at Illingworth Research. "With eTMF Connect we can now ensure that our clinical projects and trial master files are managed with greater quality and efficiency by allowing our sponsors and trial partners to centrally access and collaborate on TMF content in real-time.

Contract research organizations like Illingworth Research Group are under increasing pressure from sponsors to control clinical trial timelines and minimize costs, all while maintaining quality. By selecting eTMF Connect, a cloud-based electronic trial master file solution, Montrium was not only able to deliver a powerful tool to empower better clinical trials but also supported rapid implementation, allowing Illingworth and their partners to realize the benefits of eTMF Connect much faster than traditional enterprise systems.

"Illingworth joins a long list of leading life sciences organizations who are centralizing clinical operations and increasing their clinical trial efficiency with eTMF Connect," said Oliver Pearce, Commercialization Manager at Montrium. "Over the past 12 months, Montrium has seen incredible user growth with our cloud-based eTMF Connect product as we continue to deploy dynamic, powerful, and intuitive content management solutions at a fraction of the time and cost of traditional enterprise systems."

Montrium's eTMF Connect solution is part of Montrium Connect, a cloud-based regulated-content management platform which includes a suite of applications designed to empower life sciences organizations to delivery safer treatments to patients, faster. Montrium Connect applications support clinical, regulatory, and quality teams as they unify their content management and data across the enterprise. To learn more about the Montrium Connect platform and the powerful collection of applications, please visit www.monrium.com/connect.

About Illingworth Research Group

Illingworth Research is a well-established UK based full-service Clinical Research Organisation (CRO) with a specialist home-care research nursing solution for clinical trials at home, school or in the workplace. They have expertise in project management, monitoring, regulatory submissions and full-service capability in addition to specialist medical photography services and research nursing provision both on-site and in patient homes and regularly acts as EU Legal Representative for US Sponsors.

About Montrium

Montrium is a global leader in cloud-based document and quality management solutions and GxP consulting services for the life sciences. Operating in the life sciences for over 12 years, Montrium has been successfully helping organizations implement and maintain technology to improve their business processes and increase compliance. Montrium currently serves over 8000 users in more than 20 countries. For more information on the products and services Montrium provides, please visit: www.montrium.com.